Navigation Links
Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
Date:2/14/2013

he Company from Janssen under the collaboration and license agreement.Pharmacyclics, Inc.
Condensed Consolidated Statements of Operations(unaudited; in thousands, except per share data) Three Months EndedSix Months EndedDec. 31,Sep. 30,Dec. 31,Dec. 31, Dec. 31,20122012201120122011Revenue:  License and milestone revenue

$ 55,000$ 100,000$ 77,605$ 155,000$   77,605  Collaboration services revenue

2,9632,6952985,658335Total revenue

57,963102,69577,903160,65877,940Operating expenses*:  Research and Development

27,56719,07212,07646,63923,324  Less: Excess amounts related to Research and Development

(17,306)--(17,306)-Research and Development, net

10,26119,07212,07629,33323,324  General and Administrative

7,2254,8683,94412,0937,294  Less: Excess amounts related to General and Administrative

(819)--(819)-General and Administrative, net

6,4064,8683,94411,2747,294Total operating expenses

16,66723,94016,02040,60730,618Income from operations

41,29678,75561,883120,05147,322Interest and other income, net

77522112944Income before income taxes

41,37378,80761,904120,18047,366Income tax benefit (provision)

554(3,201)(5,651)(2,647)(5,651)Net income

$ 41,927$   75,606$ 56,253$ 117,533$   41,715Net income per share:Basic

$
.60$
.09$
.82$
.69$
.61Diluted

$
.56$
.02$
.78$
.58$
.58Weighted average shares used to computenet income per share:Basic

69,83969,51268,65869,67668,491Diluted

74,39974,45671,72574,40871,312* Includes share-based compensation as follows:Research and development

$   2,767$
2,590$   1,701$
5,357$
3,239General and administrative

1,5035766752,0791,301$   4,270$
3,166$   2,376$
7,436$
4,540Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1) '/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Pharmasset Reports Fiscal Year End 2011 Financial Results
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2014)... 2014 NSG Precision Cells has ... and spectrophotometer calibration standards for over ... released many products that have transformed the spectroscopy ... their solid-state calibration standards. , NSG’s solid-state calibration ... release in 2008. NSG started manufacturing UV ...
(Date:7/18/2014)... N.Y. , July 18, 2014 Regeneron ... its second quarter 2014 financial and operating results on ... open.  The Company will host a conference call and ... Conference Call InformationTo access this call, ... link to the webcast may be accessed from the ...
(Date:7/18/2014)... at Urbana-Champaign have demonstrated that an array of ... like traditional photographic film to record light for ... of light (for example, distances less than ~600 ... acts as a "nanocamera" whereas the pBNAs are ... the effect (writing and curing) is seen in ...
(Date:7/18/2014)... Reflecting the importance of the evolution of Houston’s real ... the founder and president of Customized Real Estate Services ... new approach to the firm’s branding. , According to ... success of his or her commercial clients have grown exponentially ... first in this market to fully embrace the potential for ...
Breaking Biology Technology:How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 3'Nanocamera' takes pictures at distances smaller than light's own wavelength 2LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2
... (Nasdaq: GNVC ) today announced that it ... Novartis (NYSE: NVS ), related to the ... The milestone was triggered by the successful completion of ... milestone reflects sustained progress and we look forward to ...
... Using clever but elegant design, University at Buffalo chemists ... to capture and purify nanomaterials. , Sculpted from a ... traps consist of tiny, organic tubes whose interior walls ... to selectively encapsulate only positively charged particles. , In ...
... TetraLogic Pharmaceuticals , a biopharmaceutical company developing novel ... announced the initiation of a Phase 1/2 clinical trial ... elderly patients with acute myelogenous leukemia (AML). The investigator-initiated ... University of Pennsylvania and is an open-label, non-randomized trial ...
Cached Biology Technology:GenVec Achieves Second Milestone in Collaboration 2GenVec Achieves Second Milestone in Collaboration 3Chemists become molecular sculptors, synthesizing tiny, molecular traps 2Chemists become molecular sculptors, synthesizing tiny, molecular traps 3TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML) 2TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML) 3
(Date:7/21/2014)... Medicine-led study suggests that parents of obese children often ... childhood weight gain or the importance of daily physical ... , The study is published online in the ... , "Parents have a hard time changing their child,s ... Rhee, MD, and an assistant adjunct professor in the ...
(Date:7/21/2014)... and Aqua satellites detected 154 hotspots in areas across ... land fires had increased again following a decline in ... report was far higher than what had been reported ... , The hotspots were scattered in six regencies and ... areas. Smoke and the related haze it creates could ...
(Date:7/21/2014)... reveals that mesenchymal (mezz-EN-chem-uhl) stem cells (MSCs) help rejuvenate ... MSCs into mouse leg muscles prior to several bouts ... during resistance training in humans that result in mild ... of repair and enhance the growth and strength of ... findings, described in the journal Medicine and Science ...
Breaking Biology News(10 mins):Parents rank their obese children as 'very healthy' 2Stem cells aid muscle repair and strengthening after resistance exercise 2
... 12 surgeons and 21 surgical residents, video game skill ... a simulated surgery skills course, according to a report ... of the JAMA/Archives journals. , James C. Rosser Jr., ... colleagues asked 33 surgeons (21 residents and 12 attending ...
... speculated that lead poisoning may have played a role in ... have been caused by the concentration of grape juice in ... damage to the environment, the annual production of lead continues ... glass, and electronic components. However, there has thus far been ...
... made to retain naturally occurring compounds called flavanols may ... and chart the course for future research that could ... dementia, according to a panel of scientists who presented ... Association for the Advancement of Science (AAAS). , Several ...
Cached Biology News:Lead with a poisonous electron shield 2Flavanols in cocoa may offer benefits to the brain 2Flavanols in cocoa may offer benefits to the brain 3